Atlas Trials

Thalidomide and Dacarbazine for Metastatic Melanoma

Clinical trial NCT00006200 · UNKNOWN

Trial details

NCT number
NCT00006200
Sponsor
National Center for Research Resources (NCRR)
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.